Mostrar el registro sencillo del ítem

dc.contributor.authorAraos, Pedro
dc.contributor.authorVergara-Moragues, Esperanza (1)
dc.contributor.authorGonzález-Saiz, Francisco
dc.contributor.authorPedraz, María
dc.contributor.authorGarcía-Marchena, Nuria
dc.contributor.authorRomero-Sanchiz, P
dc.contributor.authorCampos Cloute, Rafael
dc.contributor.authorSerrano, A
dc.contributor.authorPavón, Francisco Javier
dc.contributor.authorTorrens, Marta
dc.contributor.authorRodríguez de Fonseca, Fernando
dc.date2017
dc.date.accessioned2018-03-05T14:59:21Z
dc.date.available2018-03-05T14:59:21Z
dc.identifier.issn2159-9777
dc.identifier.urihttps://reunir.unir.net/handle/123456789/6298
dc.description.abstractCocaine continues to be a worldwide public health concern in Europe. To improve prognosis and intervention, it is necessary to understand the characteristics of the patients who depend on the services where they receive care. The objective is to analyze the differences among patients who use cocaine and between ambulatory and residential resources to better adapt treatment. This is a descriptive, observational study of two populations of cocaine users in treatment: the ambulatory therapeutic community (ATC) and the therapeutic community (TC). The PRISM diagnostic interview was used for both groups. An analysis of both populations indicates a high prevalence of cocaine, heroin, cannabis, sedative, psychostimulant, and hallucinogen use disorders in the TC population compared to the ATC. In alcohol use disorder, differences between both mental health services were not observed. The degree of severity of cocaine use disorders (CUD) is greater in the TC population. The prevalence of psychiatric comorbidity is not statistically significant between the two populations, except for primary psychotic disorders, which are more prevalent in the TC population. This difference in the prevalence of psychotic disorders may be related to the high prevalence of cannabis use disorders in TC patients. Differences in the prevalence of substance use disorders, severity of CUD, and psychiatric comorbidity may limit the efficiency of mental health services involved in substance use disorder therapeutics. These results suggest the need for careful and extensive phenotyping of patients to improve intervention and prognosis in a clinical resource-dependent manner.es_ES
dc.language.isoenges_ES
dc.publisherJournal of Psychoactive Drugses_ES
dc.relation.ispartofseries;vol. 49, nº 4
dc.relation.urihttps://www.tandfonline.com/doi/abs/10.1080/02791072.2017.1342151es_ES
dc.rightsrestrictedAccesses_ES
dc.subjectambulatory treatment centerses_ES
dc.subjectcocaine use disorderes_ES
dc.subjectpsychiatric comorbidityes_ES
dc.subjectsubstance use disorderes_ES
dc.subjecttherapeutic communitieses_ES
dc.subjectScopuses_ES
dc.subjectJCRes_ES
dc.titleDifferences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service.es_ES
dc.typeArticulo Revista Indexadaes_ES
reunir.tag~ARIes_ES
dc.identifier.doihttps://doi.org/10.1080/02791072.2017.1342151


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem